As of June 21, 2025, Axcella Health Inc (AXLA) reports a Graham Number of 3.40.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Historical Trend of Axcella Health Inc's Graham Number
Over recent years, Axcella Health Inc's Graham Number has shown limited historical data. The table below summarizes the historical values:
| Date | Graham Number |
|---|---|
| 2022-12-31 | 3.40 |
| 2021-12-31 | 3.40 |
This trend highlights how Axcella Health Inc manages its intrinsic value calculation based on earnings per share and book value over time.
Comparing Axcella Health Inc's Graham Number to Peers
To better understand Axcella Health Inc's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| Axcella Health Inc (AXLA) | 3.40 |
| Regeneron Pharmaceuticals Inc (REGN) | 500.00 |
| Moderna Inc (MRNA) | 157.32 |
| Vertex Pharmaceuticals Inc (VRTX) | 146.93 |
| Amgen Inc (AMGN) | 43.25 |
| X4 Pharmaceuticals Inc (XFOR) | 14.99 |
Compared to its competitors, Axcella Health Inc's Graham Number is among the lowest compared to peers, which may indicate relative fundamental weakness by Graham's criteria.